Vidya Perera
12PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jun 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart Disease.Antoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back
|Apr 30, 2025
Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase.Praneeth Jarugula, Toni Ajavon-Hartmann, Obinna Obianom
|Aug 13, 2024
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration.Peter Chang, Vidya Perera, David H Salinger
|May 02, 2024
Recommendation of mavacamten posology by model-based analyses in adults with obstructive hypertrophic cardiomyopathy.Samira Merali, David H Salinger, Maria Palmisano
|Jul 19, 2023
Physiologically Based Pharmacokinetic Modeling and Simulation of Mavacamten Exposure with Drug-Drug Interactions from CYP Inducers and Inhibitors by CYP2C19 Phenotype.Manting Chiang, Caroline Sychterz, Vidya Perera
|Dec 23, 2022
Effects of rifampin on the pharmacokinetics and pharmacodynamics of milvexian, a potent, selective, oral small molecule factor XIa inhibitor.Vidya Perera, Zhaoqing Wang, Susan Lubin
Pageof 2
Frequent Collaborators
4 joint publications
Samira Merali
2 joint publications
Elizabeth Ludwig
2 joint publications
Maria Palmisano
2 joint publications
Amy J Sehnert
2 joint publications
Neelima Thanneer
2 joint publications
Hyunmoon Back
2 joint publications
Amit Roy
2 joint publications
Praneeth Jarugula
2 joint publications
Toni Ajavon-Hartmann
1 joint publications
Paul Monagle
